Cite
HARVARD Citation
Raimundo, K. et al. (2013). Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS–Kaposi's sarcoma. Journal of medical economics. pp. 606-613. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Raimundo, K. et al. (2013). Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS–Kaposi's sarcoma. Journal of medical economics. pp. 606-613. [Online].